HuntingBenjmins
Posted - 6 hours ago
$IKT Love it when a company keeps their shareholders up to date! Great job!
DonCorleone77
Posted - 7 hours ago
$IKT Inhibikase Therapeutics provides update on development programs Inhibikase Therapeutics issued a Letter to Shareholders. That letter said in part:" Our 201 Trial is approximately 75% enrolled, with the last patient anticipated to enter the trial in June. We have had consistent and constructive interactions with the U.S. Food and Drug Administration for IkT-001Pro, culminating in the recent completion of a pre-IND meeting as we evaluate 001Pro's potential in cardiopulmonary disease and a pre-NDA meeting with relation to the cancer indications for which imatinib is approved. As we look forward, we recognize the urgency to initiate the 12-month extension study for our 201 trial, and we are planning our end-of-Phase 2 meeting with the FDA in Parkinson's and developing our Phase 3 protocols. In addition, we continue to evaluate potential pathways to initiate a Phase 2/3 trial in Multiple System Atrophy and continue to explore multiple indications for which IkT-001Pro could be a novel new agent....As we continue to explore the breadth of potential indications for IkT-001Pro, we believe that there is an opportunity worth exploring for Pulmonary Arterial Hypertension PAH. Our recent pre-IND meeting with the FDA was constructive and we expect to provide an update from this meeting following receipt of the formal meeting minutes. If considered a new molecular entity for PAH, IkT-001Pro might enjoy a long period of patent exclusivity....Altogether, 2024 is shaping up to be a year of execution across our portfolio."
Stock_Titan
Posted - 7 hours ago
$IKT Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
https://www.stocktitan.net/news/IKT/inhibikase-therapeutics-issues-letter-to-shareholders-and-provides-na6jd1m10qh4.html
little_jackie
Posted - 1 day ago
$IKT you continue to post untrue and/or trash statements. The company has put out 7 news releases this year. You can check their website. "Less than mediocre product." How do you come to that conclusion. At least biotechjedi wraps his bs in half-truths. Do better.
Amhtbone
Posted - 1 day ago
$IKT no press release would matter they've had 24 since January begging the FDA to approve their less than mediocre product
little_jackie
Posted - 2 days ago
$IKT trimmed my position a little. The lack of lumping (pumping with lie/deceit/half-truths) by biotechjedi and the inane posts by Amhtbone bode well for the stock, but I'm curious as to no word about the FDA meeting yet. Rejection? No insider buys yet either. Whats going on?
BillyTheKid62
Posted - 2 days ago
$IKT One solid press release to 8 bucks !
Amhtbone
Posted - 3 days ago
$IKT junk!
jemer
Posted - 6 days ago
$IKT Gleevec/Imatinib is a miracle drug when it comes to CML and 10+ other indications. CML used to be a death sentence and now 95% survive. Werner has added a product that allows for the breaching of Blood Brain Barrier and lowers toxicity. Gleevec spent hundreds of millions of dollars to develop and get approved and has saved over 100,000 lives of those suffering from CML! If throttling ABL Kinase is the key to halting and reversing Parkinson's disease, 009 will be one of the great medical breakthroughs of this century. It is imperative that Werner proves to be adept at forming partnerships. The future seems incredibly bright!
sideload
Posted - 1 week ago
$IKT anyone else feeling like we may be getting news tmrw morning ?
sideload
Posted - 1 week ago
$IKT Global PAH market size was 7.66 B in 2023. Details from the FDA meeting if we are allowed a late stage trial could rocket us … PRO safety data should count towards FDA granting us a late stage trial. And now… back to snoozing in the sun.. zzzzz
little_jackie
Posted - 1 week ago
$IKT amazing how every time you tell others to buy, claim you bought yourself, or pump this stock likes to drop. Throw in the false information you put out I'm surprised you like to call anyone who calls you out "a shorter'. Projecting much? D.
BiotechJedi1728
Posted - 1 week ago
$IKT Bought some more today at $2.17, my original average. 🤷🏻♂️ patiently waiting for next announcement. Sold some other stuff for a profit. Time to add more here. Think this is the next one to go up in a month or so.
Amhtbone
Posted - 1 week ago
$IKT 25 meetings with the FDA for pre this pre that how about granted and being packaged and shipped to destinations fucktards
Amhtbone
Posted - 1 week ago
$IKT guaranteed nothing granted nothing promised very little movement forward all talk no action repeat performance for the last 2 years
mikedar
Posted - 1 week ago
$IKT Someone sure thinks the new CFO walks on water!
HuntingBenjmins
Posted - 1 week ago
$IKT TARA had its day today. Next on deck is IKT. Load em while they’re ridiculously cheap. They are talking to FDA today.
HuntingBenjmins
Posted - 2 weeks ago
$ICU Someone else mentioned it too below but be sure to pick up some warrants at ticker ICUCW. Haven’t seen them this cheap in quite some time. Great for swinging or long hold. Look at the charts from back in Feb to see just what they are capable of!
$IKT $MCRB $TARA $ATHA
HuntingBenjmins
Posted - 2 weeks ago
$ICU I’d like to thank whomever it was that sold me those shares today at $.69
$IKT $MCRB $TARA $ATHA
HuntingBenjmins
Posted - 2 weeks ago
$IKT Good luck with your FDA meeting tomorrow Inhibikase!
$MCRB $TARA $ATHA $SPRB
https://www.inhibikase.com/news/press-releases/detail/114/inhibikase-therapeutics-announces-pre-ind-meeting-with-the
HuntingBenjmins
Posted - 2 weeks ago
$IKT FDA Meeting on Friday. People need to be jumping on here now if you dint want to miss the ride. Super company with bright future.
Amhtbone
Posted - 2 weeks ago
$IKT seriously what is the purpose of driving up the stock pre-market just to sell it 20 minutes later nobody's biting on that BS
Amhtbone
Posted - 2 weeks ago
$IKT bunch of super douches trying to hold the stock down!
BenKaitz
Posted - 2 weeks ago
$IKT
Stock_Titan
Posted - 2 weeks ago
$IKT Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension
https://www.stocktitan.net/news/IKT/inhibikase-therapeutics-announces-pre-ind-meeting-with-the-fda-for-bocma9vnet8r.html
newTrader9999
Posted - 2 weeks ago
$IKT is this one of the best midterm risk/reward right now? what else are people betting on- my bets on $ICU, $SLS and $CDTX- if I get 50% gains from those, I will transfer the gains to $IKT
jemer
Posted - 2 weeks ago
$IKT Last dose in late May means trial finishes in late August with topline results in September. What does IKT sell at after topline, if Parkinsons symptoms are halted and partially reversed? Price doesn't include 001 PDFUA run up at the same time or a partnership for 001 or funding for Parkinsons Phase 3. I'm investing on Werner's ability to get the job done!
sideload
Posted - 03/28/24
$IKT with any luck last patient dosed could be right around the 1st of May
moneymaker203
Posted - 03/28/24
$IKT just wondering if numbers are positive, why isnt the stock rising at least back to 3 Dollars ?
